Centre for Cellular and Molecular Platforms (C-CAMP) is an initiative of Dept. of Biotechnology, Ministry of Science and Technology, Govt. of India, with a mandate to be an enabler of cutting edge Life Science Research and Innovation. C-CAMP is also a member of the Bangalore Life Sciences Cluster (BLiSC, including NCBS and inStem). C-CAMP facilitates Bioscience Research and Entrepreneurship by providing Research, Development, Training and Services in state-of-the-art Technology Platforms. C-CAMP has established State-Of-The-Art Platform Technologies which are essential requirements for success and leadership in the field of Life Sciences. C-CAMP allows Investigators to use Techniques as tools and not be limited by Technological barriers while pursuing challenging scientific questions. As a part C-CAMP's mandate of promoting entrepreneurship and innovation, C-CAMP has created and fostered an entrepreneur-friendly culture in and around Academic/Research environment through its involvement in Seed Funding Schemes for Startups, Entrepreneur Mentorship program and Bio-Incubation facility.
FABA is a not-for-profit organisation with a heritage that spans over 16 years with a mission of providing a global platform for academy, industry and Government bodies to come together and interact. We partner with industry and academia in promoting innovation and entrepreneurship. We’re working to shape the future of the biotechnology – for the benefit of science and humanity. With over 1000 members and presence in over 19 nations, FABA is the world’s leading professional body for biotechnology & pharmaceutical scientists, supporting and representing our members and bringing together from all over the world. BioAsia, the global biobusiness forum, being organised for the past 16 years in Hyderabad, is the flagship event of FABA (http://bioasia.in/). In addition FABA organises workshops, seminars and distinguished lectures by eminent scientists in emerging areas of relevance to the industry in all the member countries.
KONGPOSH Publications are one of India's leading Pharma Publishers.
The Pharma Review(r) is a bi-monthly article based journal. Covering news, views and articles on various fields of pharmacy including Clinical Trials, Biotechnology, Review/Research papers, Herbal Medicine and much more. Participation and distribution in over 20 Expos & Conferences worldwide each year. It is widely read by decision makers, middle management and the academia. Also available on our website and E-book format. Indian Pharma Reference Guide (Annual) - Names and address of Pharmaceuticals, Bulk Drugs, Machinery's & Instrumentation, AYUSH Manufacturers; and much more
PharmaTutor is simply a complete pharmapedia for Pharma & Lifescience professionals.
PharmaTutor Edu Labs is publishing monthly printed & online magazine. PharmaTutor also provides important updates on jobs, projects, news, admission, conferences and events related to Pharmacy & lifescience field.
THE PHARMA WORLD is the first and the only bi-monthly Pharmaceutical and Health Journal of its kind in Bangladesh catering to the needs of Pharmaceutical Industries, Physicians, Healthcare Providers, Academicians and all other stakeholders related to this sector for the last 11 years. The Journal is also designed to disseminate information about the advancement of research & development in pharmaceutical sector and medical science, thereby constantly updating readers on this multi-dimensional segment. Besides this, THE PHARMA WORLD acts as Media Partner/Representative of many reputed International event organizers worldwide and also organize Trainings, Seminars, Workshops and Conferences relating to Pharma sector.
Pharma Utility is industry focused journal in Pharma industry that bridges the gap between industry and academia. From the beginning, Pharma Utility has been active in providing readers information on pharmaceutical equipments, machinery, laboratory tools and techniques. To help readers for acquiring more knowledge, we have decided to focus also on research in pharmaceuticals, chemicals, clinical research, biopharmaceuticals, and other related areas.
Pharma Machines & Technology is a specialised bimonthly magazine from the house of Global Vision, a familiar name in the Indian pharmaceutical industry for its outstanding trade promotional efforts.
Pharma Machines & Technology showcases the technological improvement and quality parameters of Indian pharma machinery and allied engineering sector to a world audience. The magazine features the best of the machines from reputed manufacturers and suppliers of pharmaceutical machinery in India, and displays at major international exhibitions and conferences in India and overseas round the year, being the media partner at prestigious expositions like ACHEMA Germany; P-MEC China, Sao Paulo, Spain, and India; Afro Packaging Eygpt; etc. Pharma Machines & Technology has this dedicated mission to be a catalyst of change. The articles we carry invariably reflect our mission. Our exclusives on technological developments and quality movements in pharma manufacturing are widely read by the industry. Some of the topics we regularly focus on are: Quality by Design (QbD), Pharmaceutical Quality Systems, Process Analytical Technology (PAT), Quality Risk Management (QRM), CAPA, Process Validation, Supply Chain Security, and so on, that would help create a sustainable quality culture in Indian pharmaceutical industry.
Express Pharma, launched in 1994 as Express Pharma Pulse as a weekly covering news, views and features in major functional areas of the pharmaceutical/biotech and allied industry.. Today, nearly two decades down the line, we take pride in taking this legacy further ... with the full support of our ever expanding readership, both in print and online. Express Pharma strives to present the best of India to the world as well as bringing global perspectives a platform. The fortnightly print publication spans five sections: Market, Management, Research, Pharma Ally and Pharma Life giving a varied outlook of the pharma industry. The website [www.expresspharmaonline.com] features daily real time updates on regulations, policies, researches, new launches and many more topics impacting the industry directly or indirectly.
MM Activ Sci-Tech Communications, an Integrated Media Organization with a global perspective is committed to creating brands that enable knowledge sharing and business collaboration across various areas of Science & Technology. MM Activ publishes various B2B monthly magazines BioSpectrum India, BioSpectrum Asia and NuFFoodsSpectrum, which are undisputed leaders in their space. BioSpectrum, India's first comprehensive biotech & health science monthly magazine, available both in print and Digital editions provides comprehensive coverage of the exciting happenings in life sciences, which include BioPharma, BioInformatics, BioSuppliers and BioServices across the biotech & healthcare industry. BioSpectrum Asia covers a roundup of the happenings in Biotech, Pharma and Medtech industry segments in Asia Pacific region. BioSpectrum has emerged as the most preferred platform to engage the life sciences industry in India and Asia Pacific. NuFFoods Spectrum, India's first integrated B2B magazine caters to the Nutraceuticals, Nutritionals, Functional Foods and Dietary Supplements sector. The magazine covers the latest news, captures emerging trends, in-depth study and analysis in the sector
Biosimilar Development is dedicated to presenting technical information, thought leadership, and commentary for the biosimilar development and manufacturing community. On this site, users will find exclusive and actionable content on the industry trends and challenges affecting the emerging biosimilars market. Browse our articles, case studies, and white papers on topics related to biosimilar development, manufacturing, quality, distribution, FDA guidance, BPCIA, global markets, government regulations, and intellectual property.
Biosimilar Development is part of the Life Science Connect media group, which strives to facilitate connections and foster collaborations in pharmaceutical development to find ways to get more life-saving and life-improving therapies to market. Connect, Collaborate, Contribute.